Development and clinical validation of a novel 9-gene prognostic model based on multi-omics in pancreatic adenocarcinoma

D Xu, Y Wang, X Liu, K Zhou, J Wu, J Chen… - Pharmacological …, 2021 - Elsevier
The prognoses of patients with pancreatic adenocarcinoma (PAAD) remain poor due to the
lack of biomarkers for early diagnosis and effective prognosis prediction. RNA sequencing …
被引用次数：37 相关文章

Development and clinical validation of a novel 9-gene prognostic model based on multi-omics in pancreatic adenocarcinoma

D Xu, Y Wang, X Liu, K Zhou, J Wu… - Pharmacological …, 2021 - pubmed.ncbi.nlm.nih.gov
The prognoses of patients with pancreatic adenocarcinoma (PAAD) remain poor due to the
lack of biomarkers for early diagnosis and effective prognosis prediction. RNA sequencing …

Development and clinical validation of a novel 9-gene prognostic model based on multi-omics in pancreatic adenocarcinoma.

D Xu, Y Wang, X Liu, K Zhou, J Wu, J Chen… - Pharmacological …, 2020 - europepmc.org
The prognoses of patients with pancreatic adenocarcinoma (PAAD) remain poor due to the
lack of biomarkers for early diagnosis and effective prognosis prediction. RNA sequencing …